Glenmark Shares Soar 3% on Approval to Start Phase 3 Trial
Shares of Glenmark Pharmaceuticals Ltd soared 3% on Friday, 4 September, after the company announced securing approval from DCGI. Glenmark Pharmaceuticals’ shares surged after the...
Tag : Phase 3 Clinical trial
Shilpa Medicare Shares Skyrocketed 11% Successful Phase 3 Clinical Trial
The shares of Shilpa Medicare Ltd skyrocketed 11% on 26 August following the company’s announcement of a positive result in Phase 3 trials for SMLNUD07,...